(Q88248409)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

title

Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Andrew J Plodkowski

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Victor D Martinez

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Christopher Matheny

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Alexander Drilon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Romel Somwar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Biju P Mangatt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Henrik Edgren

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Patrice Desmeules

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Anja Ruusulehto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Roger S Smith

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Lukas Delasos

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Joshua Sabari

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Kenneth Ng

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Joseph Montecalvo

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Jason Chang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Huichun Tai

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

William W Lockwood

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Gregory J Riely

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Charles M Rudin

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Mark G Kris

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Maria E Arcila

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Ryma Benayed

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Natasha Rekhtman

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Marc Ladanyi

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Gopinath Ganji

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

publication date

2 April 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

686-695

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.

22 March 2020

cites work

1 reference

12 December 2020

Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells

1 reference

12 December 2020

A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.

1 reference

12 December 2020

An Antibody That Locks HER3 in the Inactive Conformation Inhibits Tumor Growth Driven by HER2 or Neuregulin

1 reference

12 December 2020

Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.

1 reference

12 December 2020

The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells.

1 reference

12 December 2020

CD74-NRG1 fusions in lung adenocarcinoma.

1 reference

12 December 2020

Druggable oncogene fusions in invasive mucinous lung adenocarcinoma.

1 reference

12 December 2020

Molecular Pathways: Targeting NRG1 Fusions in Lung Cancer.

1 reference

12 December 2020

Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor models

1 reference

12 December 2020

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology

1 reference

12 December 2020

Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.

1 reference

12 December 2020

First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors.

1 reference

12 December 2020

Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit.

1 reference

12 December 2020

Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung

1 reference

12 December 2020

NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma

1 reference

12 December 2020

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

1 reference

12 December 2020

Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions

1 reference

12 December 2020

Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3.

1 reference

12 December 2020

Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance.

1 reference

12 December 2020

Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer.

1 reference

12 December 2020

A Case of Invasive Mucinous Pulmonary Adenocarcinoma with a CD74-NRG1 Fusion Protein Targeted with Afatinib.

1 reference

12 December 2020

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.

1 reference

12 December 2020

Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression.

1 reference

12 December 2020

10.1158/2159-8290.CD-17-1004

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29610121%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference